...prespecified interim analysis of the pivotal Phase III DUPLEX study. Shares of the company, formerly Retrophin Inc....

...and secondary endpoints in a Phase III trial.Retrophin...
...Initiative (IAVI) Merck KGaA Serum Institute of India Pvt. Ltd. Retrophin Inc. The...

...proposed after-hours to raise $100 million. On Thursday, CareDx’s stock fell $3.29 (10%) to $30.22. Retrophin Inc....
...million Wednesday. Elizabeth S. Eaton, Staff Writer Moderna Inc. Guardant Health Inc. Allogene Therapeutics Inc. Catalent Inc. ChemoCentryx Inc. Fate Therapeutics Inc. CareDx Inc. Retrophin Inc. Replimune...

...COO. Poole was COO at LogicBio Therapeutics Inc. (NASDAQ:LOGC) and serves on the boards of Retrophin Inc....

...COO. Mayer has been with the immunotherapy company since its 2015 founding. Rare disease play Retrophin Inc....
...Lori Reilly, who became COO on Sept. 17. BioCentury Staff Torque Therapeutics Inc. Pact Pharma Inc. Deciphera Pharmaceuticals Inc. NextCure Inc. Retrophin Inc. Vor...

...With plans to discontinue fosmetpantotenate after its Phase III miss, Retrophin President and CEO Eric Dube...
...Retrophin Inc. (NASDAQ:RTRX) down $3.84 (22%) to $13.56 Thursday, well below its 52-week high of $33. Retrophin...
...nephropathy. The company expects top-line data from DUPLEX and PROTECT in 1H21 and 1H22, respectively. Retrophin...

...for NGLY1 deficiency, companies including Retrophin Inc. and Glycomine Inc. have preclinical programs for the disorder. Retrophin...
...Menlo Park, Calif. Reata Pharmaceuticals Inc. (NASDAQ:RETA), Irving, Texas Regeneron Pharmaceutical Inc. (NASDAQ:REGN), Tarrytown, N.Y. Retrophin Inc....

...events (MACE) in patients with Type II diabetes and high HDL Phase III data YE19 Retrophin Inc....

...a biomedical business this year in North America. Retrophin partners with NCATS on Alagille treatment Retrophin Inc....
...MK-7339) Amgen Inc. AstraZeneca plc Bristol-Myers Squibb Co. Catalent Inc. Merck & Co. Inc. Myriad Genetics Inc. National Center for Advancing Translational Sciences Retrophin Inc. University...

...gene therapy company. MeiraGTx said COO Richard Giroux will take on the role of CFO. Retrophin Inc....
...protein 173; TNFSF13 (APRIL) - Tumor necrosis factor ligand superfamily member 13 BioCentury Staff Aduro Biotech Epic Sciences MeiraGTx Neurelis Prime Therapeutics Retrophin Sofinnova...